<

 
Data updated 2025-06-03 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date11791161.0 (espacenet)  (Federated)  (European Patent Register), 20111118
Patent/reg. no. and dateDK/EP 2640362, 20140910
Publication date20130925
Priority no. and dateUS 415600 P, 20101119
EP pub. no. and date EP 2640362 20130925
Effective date
Applicant/ownerGilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US,
Janssen Sciences Ireland UC, Eastgate Village, Eastgate
Little Island, County Cork, IE
Applicant ref. no.V161118DK
InventorOLIYAI, Reza, 1504 Alturas Drive
Burlingame
California 94010, US,
WISER, Lauren, 10093 Senate Way
Cupertino
California 95014, US,
MENNING, Mark, 9 Hugo Street
San Francisco
California 94122, US
RepresentativeMarks & Clerk LLP, 44 rue de la Vallée BP 1775 L-1017 Luxembourg, LU
Opponent
IPC ClassA61K 31/505 (2006.01) , A61K 31/513 (2006.01) , A61K 31/675 (2006.01) , A61K 9/20 (2006.01) , A61P 31/18 (2006.01) 
TitleTERAPEUTISKE SAMMENSÆTNINGER, DER OMFATTER RILPIVIRIN HCL OG TENOVOFIR-DISOPROXILFUMARATE
Int. application no.US2011061515
Int. publication no.WO2012068535
Related patent (certificate)
StatusÆndret DK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact